A widely available antiviral medication offers new possibilities for long Covid patients seeking relief from debilitating symptoms. Research shows extended Paxlovid treatment could help restore ...

These companies headline a $1.4 trillion industry, have staying power, and will pay you well to hold their stock.

January is a big time for drugmakers to hike prices. This year saw higher prices for 575 medications so far, including ...

Pfizer CEO highlights savings, leadership changes, and acquisition-driven growth amid significant revenue loss challenges ...

Wedmont Private Capital lessened its position in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 17.7% in the fourth ...

Four in 10 Minnesotans who contracted COVID-19 reported in a new state survey that they struggled with lingering health ...

Brookstone Capital Management trimmed its stake in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 11.9% in the fourth ...

At the JPM conference, Pfizer CEO Albert Bourla projected optimism, saying the market was overlooking the pharma company's ...

Federal science agencies have renewed and increased funding for a world-renowned digital archive of protein structures housed ...

In the winter months, it seems few are safe from some kind of illness — flu, COVID-19, norovirus, colds, and that’s definitely the case right now for Georgia and South Carolina.